Study Condition(s): Adult Type 2 Diabetes

A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Study Alias: BDCM

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT03736785 {{ currentLocaleObject.registryAnchorText }}

Recruiting Recruiting

Study Purpose

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18+ years

Time Commitment

The study will last about 39 weeks and may include up to 23 visits.
  • Participant must have type 2 diabetes mellitus (T2DM) treated with basal insulin and up to 3 of the following oral antihyperglycemic medication (OAM): • DPP-4 inhibitors • SGLT-2 inhibitors • biguanides • alpha-glucosidase inhibitors • sulfonlyureas

  • Participant must not have type 1 diabetes mellitus or latent autoimmune diabetes

  • Participant must not have any episodes of severe hypoglycemia and/or hypoglycemia unawareness within the 6 months prior to screening

  • Participant must not have had a heart attack or stroke in the past 2 months or have heart failure that significantly limits their physical activity

  • Participant must not have acute or chronic hepatitis, or obvious clinical signs or symptoms of any other liver disease

  • Participant must not have active or untreated cancer

  • Participant must not have had Chronic (>14 days) systemic glucocorticoid therapy

Where to Participate

46 locations are currently available of 54 planned
Invalid Postal Code.
Please re-enter postal code.
Alert Me Icon Sign up for email alerts about new Lilly trials and locations.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}
Alert Me Icon Sign up for email alerts about new Lilly trials and locations.

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.